Introduction: glucose 6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy with a relatively high frequency in malaria-
Introduction
Malaria remains to be a public health concern with 429,000 reported associated deaths in 2015 in spite of the effort to control and eventually eliminate it has recorded huge success in the last decades worldwide [1] . Malaria is a public health concern in Eritrea although the country has scored tremendous achievements in its control over the past 15 years through intensive control interventions [2, 3] .
Eritrea is located in the horn of Africa, where 67% of its populations live in malaria risk areas [4] . Plasmodium falciparum is responsible for 67% of malaria cases and Plasmodium vivax for 30%; there is a small percentage of cases due to mixed infections [5] . Eritrea has an estimated population of 5.19 million people [6] with nine officially recognized ethnic groups (Afar, Bilen, Hidareb, Kunama, Nara, Rashida, Saho, Tigre and Tigrigna). Tigrigna is the largest ethnic group followed by the Tigre group, whereas Rashaida is the smallest ethnic group in the country. Administratively, the country is divided into six zobas (regions): Maekel, Anseba, Gash Barka, Debub, Semienawi Keyih Bahri (Northern Red Sea) and Debubawi Keyih Bahri (Southern Red Sea). Among these zobas, Debub, Semienawi Keyih Bahri, Anseba and Gash Barka are endemic to malaria. Malaria in the country is mostly seasonal and unstable. The disease is transmitted through the Anopheles arabiensis primary vector, which is difficult to control using conventional interventions method due to its facultative indoor and/or outdoor feeding and resting behavior [7] . G6PD is a cytosolic enzyme present in all cells [8] and functions in the body's defense against oxidant damage [9] . In red blood cells (RBCs), G6PD is the only source of NADPH cofactor, which is needed for generating a reduced glutathione (GSH), the major antioxidant defense. G6PD gene encoding the G6PD enzyme is located on X chromosome and is highly polymorphic with more than 400 variants, described based on biochemical diagnosis [10] . G6PD deficiency is the most prevalent enzyme deficiency in humans [11] present in over 400 million people worldwide [12] with an estimated allelic frequency of 8% across malaria endemic countries [13] . As X-linked disorder, the transmission pattern results in G6PD deficiency hemizygous males or homozygous females, whereas heterozygous females can be either normal or deficient in G6PD activity because of mosaicism [14] .
Although most individuals with G6PD deficiency are clinically asymptomatic, this defect causes neonatal jaundice, mild hemolytic anemia and chronic non-spherocytic hemolytic anemia triggered by infections, specific foods (fava beans), or drugs [15] . On the other hand, G6PD deficiency has protective power against malaria infection although whether this advantage is exclusive to heterozygous female individuals, or it is shared by both sexes equally has been controversial [16, 17] . A case-control study performed on the coast of Kenya showed that only girls who were heterozygotes for the G6PD c.202T (G202A) variants were significantly protected from severe and complicated Plasmodium falciparum malaria [18] . Recent studies also revealed an increasing levels of G6PD deficiency associated with decreasing risk of cerebral malaria, but with increased risk of severe malarial anaemia [19] . To date, more than 400 G6PD variants have been identified, of which 186 variants are associated with G6PD deficiency by decreasing the activity or stability of G6PD [9, 20, 21] .
However, in sub-Saharan Africa three variants occur with polymorphic frequencies (> 0.1%): G6PD*B, G6PD*A and G6PD*A-. G6PD*B is the wild type and the most common variant in Africa and worldwide.
G6PD*A has a single A→G substitution at nucleotide number 376. It is a normal variant with about 90% of the G6PD*B enzyme activity [22] . G6PD*A-is a deficient variant with about 8-20% of the wild type enzyme activity and caused by the A376G and G202A mutations [23] .
G6PD Mediterranean variant is caused by the C563T mutation with less than 10% enzyme activity and found in Italy, Cyprus and in the Middle East [9] . In Eritrea, there is scant knowledge of G6PD 
Methods
Study sites and study population: this cross-sectional study was undertaken at 10 study sites located in five zobas of Eritrea ( Figure   1 ) between August and October 2016. Study sites were selected based on practical accessibility, on the availability of malaria cases and geography. The number of study participants enrolled from each study site was determined using probability proportional to size (PPS).
To limit double sampling of genetically related individuals, a single individual per family was recruited. Individuals born from parents of two different ethnic groups were excluded from this study.
Microscopic examination of malaria parasite: outpatients visiting health stations/centres/hospitals and those clinically suspected to have malaria were diagnosed for Plasmodium species by microscopy. Thick and thin blood smears and dried filter paper blood spots (DBS) were made from a drop of finger-prick blood. After the slides were air-dried, the thin smear fixed in methanol and both smears were stained with 10% Giemsa for 15 minutes. The stained slides were subsequently air-dried and viewed under 100X oil immersion microscope (Olympus microscope CX21, Tokyo, Japan). An experienced microscopist read the slides. Species identification was done by visualizing thin blood smear. Parasitaemia was determined as the percent of malaria parasites observed per 200 white blood cells [24] . were further amplified using primers for G202A: G6PD3/4F (5'-AACCACACACCTGTTCCCTC-3') and G6PD3/4R (5'-GCTGGTAGAGAGG GCAGAAC. Amplicons were incubated at 37°C for 50 min with NlaIII to identify the G6PD A-(G202A) variant. DNA was amplified using primers, G6PD6F (5'-TGCAGCTGTGATCCTCACTC-3'
and G6PD6R (5'-AGGTGGAGGAACTGACCTTG-3'). PCR products were then incubated at 37°C for 40 minutes with MboII to identify the G6PD Mediterranean (C563T) variant. All RFLP products were separated by 3% nusieve-agarose gels stained with midori green dye at occurrence of 100 bp DNA size marker. Gels were visualized using UV light and sex was determined by the number of bands (three for females and two for males).
DNA sequencing: to confirm RFLP analysis results, samples
showing positive for A375G, but negative for G202A variants were further analyzed by DNA sequencing in one direction [26] . A subset of PCR products of exon 5 of the G6PD gene was also directly sequenced to identify A376G and other mutations. PCR products of G6PD exons, 3+4 and 5 were amplified using forward primers previously described in Tishkoff et al. [25] . PCR thermal cycling protocol was performed as previously described in Promega Madison, USA. PCR products were purified using ExoSap enzymes (USB, Affymetrix, USA) and subjected to cycle sequencing using Big Dye Phylogenetic analysis: phylogenetic analysis was performed using the nucleotide sequences obtained from G6PD exon 5 PCR products.
The nucleotide sequences were first manually edited by removing ambiguous sequences at the ends and generating reverse complements, which were then aligned using a Geneious version 11.1 [27] . Human G6PD exon 5 sequence was extracted from NM_001042351.2 and GRC38/hg38 reference sequences in the NCBI nucleotide and human genome databases were used as wildtype allele B controls. Sample sequences with more than two mismatches to wildtype were assumed to contain sequence errors whereas sample sequences with only one or two mismatches to wildtype were assumed possibly to represent genuine variants. Multiple sequence alignments by Clustal Omega version 1.2.4 were generated using a previously identified uncommon Ethiopian G6PD variant (rs782669677) from West Ethiopia [28] 
Results
To characterize and determine the prevalence of common G6PD 
A hemizygous males (type A). The highest proportion of G6PD
A variant was observed in males (13.1%) than in females (11.9%).
Bivariate logistic regression analysis revealed no statistically significant difference between G6PD A variant and sex (P > 0.05). and a statistically significant difference of A376G variant and zoba was observed (P < 0.004 < 0.05). The distribution of G6PD B and G6PD A (A376G) with respect to demographic data in malaria patient Eritrean ethnic groups is summarized in Table 2 . In this study, G6PD A-(G202A) and Mediterranean (C563T) variants were also successfully genotyped in the analyzed population. Of the 311 genotyped malaria patients, 0.00% (0/311) carried the G202A and C563T variants. (272/311) among the malaria patients, which is in line with the literature that the wild type G6PD B allele is the most common variant in Africa and worldwide [22] . Similarly, other authors found a high prevalence of G6PD B genotype in Burkina Faso (74.5%) [11] and reported 53.6-81.5% among inhabitants of sub-Saharan Africa (Sierra Leone, Mende, Temne, Ghana, Fante, Ga, Cameroon, and Bakaka) [25] . The overall prevalence of G6PD A variant was 12.5% observed in the analyzed microscopically diagnosed malaria patients. Of the 39 (12.5%) genotyped individuals with A376G variant, 4.8% were heterozygous females , 0.32% was a homozygous female, and 7.4%
were homozygous males for A376G variant, which is in agreement with previously reported results from Ethiopia, of which 23.26%
(20/86) genotyped malaria patients with A376G variant, 19 were heterozygous females and one hemizygous male carried the A376G mutation [28] . The prevalence of G6PD A variant by sex was 11.9% in females and 13.1% in males in this study, but these difference are not statistically significant (P > 0.05). The higher prevalence of G6PD deficiency in male is consistent with other studies conducted in
Afghanistan [29] and Solomon Islands [30] . The male predominance of G6PD deficiency can be attributed to the X-linked inheritance in G6PD gene [9] . The prevalence of the A376G variant in terms of frequency among the ethnic groups ranged from 0.00% to 21.4%.
Similar results were reported from a study done by G6PD fluorescent spot test among unrelated males of Karen (4.1%) and Burman (12.9%) ethnic groups in a malaria endemic region on the ThailandMyanmar border [31] and in five ethnic groups in Pakistan [32] . In this study, higher G6PD A (A376G) variant prevalence was found to be associated with individuals residing in zoba Debub (28.3%) followed by zoba Gash Barka (12.4%) and these differences were statistically significant (P < 0.004 < 0.05) which is in agreement with previous findings in Ethiopia and Nepal [33, 34] . Notably, the 8.3%
of malaria patients with the A376G variant recorded in zoba Maekel, which is considered malaria free zone of Eritrea. These individuals who are mainly Tigrigna and Tigre ethnic groups resided and/or temporarily travelled to different zobas, and they had come for their medical treatment. The frequency of G6PD did differ by zoba (region) due to differing ethnic make-up of each zoba. As conclusion, the frequency of G6PD deficiency differed across the world depending on the ethnic groups and regions [13] [14] [15] 35] .
Considerable evidences showed that in African populations the G6PD
A-(G202A/A376G) mutations is exclusively the cause of G6PD
deficiency. Few studies reported G6PD A-(202GA) frequency estimates considerably lower than those generally found in subSaharan Africa [10] and confirmed by a recent geostatistical modelbased map that predicted a 1.0% prevalence [15] . The prevalence G202A deficient variant was zero (0.0%) in this study, which is in line with the study findings in Ethiopia [28, 36] and Northern Sudan [37] .
In contrast, the frequency of G6PD A-deficient variant was higher in Uganda (20.41%) and in Mali (7.9%) respectively [38, 39] . The absence of G6PD A-mutation in this study could be due to geographical location and the molecular heterogeneity of G6PD deficiency among different populations [40] . G6PD Mediterranean variant is primarily found in populations within the Mediterranean region [41, 42] . The prevalence of the G6PD Mediterranean (C563T) mutation in terms of frequency was zero (0.00%) in this study, which is in accordance with studies done in Angola [43] and in Ethiopia [28] .
In contrast, Mediterranean mutation is the second most common to Ethiopia, malaria patients Eritrean population in this case have a much lower prevalence of the common A376G variant, but a higher prevalence of the rarer G451C mutation. Bioinformatic analysis of these mutations' suggests that they have minimal effect on G6PD protein function [28] .
Conclusion
This study is the first report on molecular characterization and the prevalence of G6PD allelic variants in microscopically confirmed malaria patients in Eritrea. PCR-RFLP results and DNA sequencing showed the prevalence of non-deficient G6PD B and G6PD A (A376G) variants while the G202A and C563T variants were absent in this study. The discovery of uncommon mutations one potentially novel mutation gives the impetus for further investigation into G6PD variation in Eritrea. Our findings can contribute in filling the knowledge gap to the overall molecular characterization and prevalence of G6PD genotypes in Eritrea and in world populations.
The presented data suggest the use of primaquine treatment without considerable safety concerns in Eritrea. Further studies including phenotypic approaches are needed to confirm the observed results.
Some limitations exist in the study. The sample size of certain ethnic groups was very small in this study, thus more data is required from each ethnic groups to accurately estimate the prevalence of G6PD
genotypes in Eritrean population. There was lack of positive internal quality control material for G6PD deficient C563T variant and was not confirmed by sequencing due to fund constraint.
What is known about this topic
 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is X-linked hereditary defect affects over 400 million people particularly males;
 G6PD has over 186 mutations responsible for G6PD deficiency;
 G6PD deficiency is the most common in malaria endemic areas and has a protective power against malaria.
What this study adds
 This study is the first of its kind carried out to characterize and determine prevalence of common G6PD variants in Eritrea;
 Assessed the distribution of G6PD variants among the ethnic groups;
 Tables and figure   Table 1 : total of 314 dried blood spot samples collected from eight ethnic groups per zoba and study site 
